Navigation Links
GenVec Reports Fourth Quarter And 2012 Year-End Financial Results
Date:3/22/2013

s decreased 18% to $14.3 million in 2012 from $17.4 million in 2011.  In 2012 we experienced lower research and development costs than in the prior year due primarily to decreased manufacturing costs in the hearing and FMD programs, the closeout of the PACT trial, reduced personnel costs as a result of our reduction in force, reduced material costs for our funded programs, and reduced equipment purchases under our hearing and FMD programs.  These decreases were partially offset by increased outside costs for our other research programs as compared to 2011.

General and administrative expenses increased 17% to $9.1 million in 2012 from $7.8 million in 2011.  General and administrative expenses were higher in 2012 primarily due to personnel costs, which included approximately $1.3 million in non-recurring employment costs.

Fourth Quarter 2012 ResultsFor the fourth quarter ended December 31, 2012, GenVec reported a net loss of $3.2 million, or $0.24 per share, compared with a net loss of $2.5 million, or $0.19 per share, for the comparable prior year period.  The Company reported revenues of $1.5 million in the fourth quarter of 2012 compared to $3.4 million for the same period in 2011.  This decrease was primarily due to reduced revenue related to both our hearing loss and balance disorders program, $1.3 million, and FMD program, $0.2 million.  Reduced revenue in each case is due to a reduced work scope in the 2012 period as compared to the same period in 2011.  Research and development expenses decreased 21% in 2012 from $3.9 million in the fourth quarter of 2011 to $3.1 million in the fourth quarter of 2012 due mainly to reduced personnel and manufacturing costs.  General and administrative expenses in the fourth quarter of 2012 decreased 20% to $1.6 million from $2.0 million in the comparable period in 2011 primarily due to decreased personnel and recruiting costs, partially offset by higher professional costs.
'/>"/>

SOURCE GenVec, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
2. GenVec Appoints Cynthia Collins as President and CEO
3. GenVec Reports Inducement Award
4. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
5. GenVec to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 9, 2012
6. GenVec Reports Second Quarter 2012 Financial Results
7. GenVec Reports Third Quarter 2012 Financial Results
8. GenVec to Present at 25th Annual ROTH Conference
9. GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013
10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
11. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... , Aug. 3, 2015 Immune Pharmaceuticals, Inc. ... Dr. Daniel Teper , will present live at ... 6, 2015 TIME:   11:30AM EDT LINK:    http://tinyurl.com/aug6-pre-imnp ... interactive online event where investors are invited to ask ... presentation hall as well as the association,s "virtual trade ...
(Date:8/3/2015)... SAN DIEGO , Aug. 3, 2015  Sorrento ... that it has entered into an exclusive licensing agreement ... or biobetter antibodies from Mabtech Limited, a holding company ... China . Under the ... these 4 monoclonal antibodies (mAbs) for the North American, ...
(Date:7/31/2015)... , July 31, 2015  In today,s ever-changing marketplace, ... are increasingly mobile, increasingly connected, and increasingly impatient with ... of customer interaction channels and tools is driving call ... media. According to research by benchmarking ... counter (OTC) segment in a call center study realize ...
Breaking Medicine Technology:Immune Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com August 6 2Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 2Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 3Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 4Best Practices in Building World-Class Consumer & Over-the-Counter Call Centers 2
... , ABBOTT PARK, Ill., July 28 ... Food and Drug Administration (FDA) approval for two new ... SIMCOR dosage strengths combine 40 mg of simvastatin – ... either 500 mg or 1,000 mg of niacin extended-release. ...
... In FDLI,s latest monograph, Selling Pharmaceuticals and Biologics to ... , Joy Sturm , Allison Pugsley ... Hogan Lovells US LLP detail how pharmaceutical and ... price calculation requirements. The 73-page monograph (Volume 1, #5) succinctly ...
Cached Medicine Technology:Abbott's SIMCOR ® ( niacin extended-release / simvastatin ) Receives FDA Approval for New Dosage Strengths 2Abbott's SIMCOR ® ( niacin extended-release / simvastatin ) Receives FDA Approval for New Dosage Strengths 3New FDLI Monograph Provides Expert Guidance on Selling Pharmaceuticals, Biologics to Federal Government 2
(Date:8/3/2015)... ... August 03, 2015 , ... Bodybuilding.com, ... of nutritional supplements, has officially opened the polls for their eleventh annual ... following categories:, ,     Brand of the Year (BPI Sports) ...
(Date:8/3/2015)... , ... August 03, 2015 , ... The art of ... Learning from her grandmother’s side at a young age, Nasreen Zereshki was extremely eager ... decided to share her cookbook Recipes from My Persian Kitchen with the world. , ...
(Date:8/3/2015)... ... August 03, 2015 , ... It’s ... Ahjumawi Lava Springs, California’s northernmost and among its least visited State Parks. The ... aquifers, whose main outflow is at Ahjumawi Lava Springs, part of the Fall ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... is predicted to decline by 39 percent, according to market research compiled for ... includes data from the U.S. Department of Labor, Bureau of Labor Statistics. As ...
(Date:8/3/2015)... ... 03, 2015 , ... Constantin Vasilica, 48 from Romania wanted to have an ... after many years of suffering and using medications with strong side effects. This had ... for extra time off or wait longer hours in the waiting rooms. Instead, he ...
Breaking Medicine News(10 mins):Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 2Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 3Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 4Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 2Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 3Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3
... ... Letters—for Temperature, Humidity and other Controlled Environments” , ... (Vocus) April 29, 2010 -- ... and other Controlled Environments” is now available from Veriteq ( www.veriteq.com ), ...
... beneficial, researchers say , THURSDAY, April 29 (HealthDay News) ... deep brain stimulation surgery in addition to treatment with ... the procedure, patients who underwent the surgery reported better ... and engage in routine daily activities compared to those ...
... , ... is a saying that seems to ring true according to husbands whose wives have had ... Surgery takes a look at the transformative journey from the husband,s perspective. , ... Newport Beach, Calif (Vocus) April 29, 2010 ...
... ... NeverTouch® laser fiber , ... Albany, N.Y. (PRWEB) April 29, 2010 -- AngioDynamics (NASDAQ: ANGO) announced today that ... expected to be featured in a segment on the popular television show "The Doctors.", ...
... ... of pool security results in the death of 100’s of children around the world. Despite it ... posing a serious risk. , ... 29, 2010 -- Du Toit & Associates plead to all swimming pool owners to follow swimming ...
... ... Awareness of Symptoms of Brain Aneurysms , ... Boston, MA (PRWEB) April 29, 2010 - On April 23, ... Seventy to eighty percent of spontaneous subarachnoid hemorrhages are caused by ruptured cerebral ...
Cached Medicine News:Health News:Guide for US FDA-Regulated Organizations Now Available 2Health News:Guide for US FDA-Regulated Organizations Now Available 3Health News:Adding Surgery to Meds May Improve Life With Parkinson's 2Health News:Cruise Plastic Surgery Looks at Mommy Makeovers from the Husband's Perspective and Offers Tips 2Health News:Cruise Plastic Surgery Looks at Mommy Makeovers from the Husband's Perspective and Offers Tips 3Health News:Cruise Plastic Surgery Looks at Mommy Makeovers from the Husband's Perspective and Offers Tips 4Health News:AngioDynamics' VenaCure EVLTTM System for Varicose Veins To Be Featured On 'The Doctors' National Television Program 2Health News:AngioDynamics' VenaCure EVLTTM System for Varicose Veins To Be Featured On 'The Doctors' National Television Program 3Health News:AngioDynamics' VenaCure EVLTTM System for Varicose Veins To Be Featured On 'The Doctors' National Television Program 4Health News:Du Toit & Associates Prepare to Prevent Silent Deaths by the Pool this Summer 2Health News:Early Detection Makes a Difference in the Treatment of Brain Aneurysms 2Health News:Early Detection Makes a Difference in the Treatment of Brain Aneurysms 3
A single tube that performs two rapid tests for E. coli from culture. ColiScreen™ combines both the indole test with the glucuronidase test to increase the specificity....
Legionella provides rapid, accurate results that aid in the presumptive diagnosis of Legionella infection (Legionnaires' Disease)....
... Captia™ Legionella pneumophila IgG/IgM Enzyme-Linked ... for the qualitative detection of ... to Legionella pneumophila (Legionella) serogroups ... with clinical suspicion of Legionella ...
The GoodKnight® 425 Bi-Level® device is suitable for travel and includes features such as automatic altitude compensation, optional cigarette lighter adapter and portable battery pack...
Medicine Products: